The efficacy of these interventions in improving insulin sensitivity and cognitive function underscores the potential for personalized approaches to prevent and treat metabolic and neurodegenerative diseases (Kootte et al., 2017; Matt et al., 2018). This evidence concerns the gene INS and neurodegenerative disease.